Suggestions
Michael King
Partner at Hibiscus Biotechnology; Chief Business Officer and CFO at clinical stage biotechs
Michael King is a highly accomplished professional with a diverse background in the pharmaceutical and healthcare industries.
He holds a Master of Business Administration (MBA) from Columbia Business School and a Bachelor of Arts (BA) from Wesleyan University.
Michael has held key positions in various organizations, currently serving as a Partner at Hibiscus Bioventures, LLC.
Prior to his current role, he was the Chief Business Officer at Adaptive Phage Therapeutics and held senior positions at companies like Akari Therapeutics Plc, ATRIN PHARMACEUTICALS, PDS Biotechnology, and Belrose Pharma.
His extensive experience also includes serving as an Advisory Board Member at Aprecia Pharmaceuticals and in leadership roles at Sandoz Inc., McKinsey & Company, and Petrie Parkman & Co.
Michael King's expertise spans business development, commercial operations, financial management, and strategic planning within the healthcare sector.
His contributions to numerous organizations reflect his strategic vision and ability to drive business growth and innovation.
With a solid educational foundation and a wealth of practical experience, Michael continues to make significant contributions to the pharmaceutical industry.
His leadership roles and advisory positions testify to his industry knowledge and business acumen, making him a sought-after professional in the pharmaceutical and healthcare space.
